New perspectives on management of late effects of head & neck cancer treatment
Kate Hutcheson,
USA
This session will offer multidisciplinary perspective on innovations in patient-reported and clinician-graded surveillance of late effects, highlighting QOL measurement and imaging of mandibular osteoradionecrosis as two examples. Inflammation as a mediator of post-sickness syndrome will be explored as a novel mechanism of late effects in head and neck cancer survivors.
0100
Symposium